Brief: Sanofi Starts Work On Insulin Facility In Germany
Mon 11:34
BRIEF-Sanofi Starts Work On Insulin Facility In Germany Oct 19 (Reuters) - Sanofi SA SASY.PA:
SANOFI BREAKS GROUND ON NEW STATE-OF-THE-ART INSULIN MANUFACTURING FACILITY AT BIOCAMPUS IN FRANKFURT IN GERMANY
SANOFI - FULL INSULIN API PRODUCTION PLANNED FOR 2032
SANOFI - FRANKFURT BIOCAMPUS HAS 4,000 EMPLOYEES AND SUPPLIES 20 INSULIN PRODUCTS
Source text: ID: nGNX3J12yX
Further company coverage: SASY.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00; ))
Recent news on Sanofi SA
See all newsEdenTree fund manager Hiorns has bought up French stocks despite civil unrest (updated)
Early US flu season, current strain may signal risk for younger people; doctors urge shots
Brief: Sanofi Starts Work On Insulin Facility In Germany
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Europe Research Roundup: AJ Bell, CMC Markets, Nestle